Trial · NCT00435045
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Weeks 1-8 / 10 mg Dose Level | STARTED | Lovaza(Omacor) + Atorvastatin | 123 | |
| Weeks 1-8 / 10 mg Dose Level | STARTED | Placebo + Atorvastatin | 122 | |
| Weeks 1-8 / 10 mg Dose Level | COMPLETED | Lovaza(Omacor) + Atorvastatin | 118 | |
| Weeks 1-8 / 10 mg Dose Level | COMPLETED | Placebo + Atorvastatin | 118 | |
| Weeks 1-8 / 10 mg Dose Level | NOT COMPLETED | Lovaza(Omacor) + Atorvastatin | 5 | |
| Weeks 1-8 / 10 mg Dose Level | NOT COMPLETED | Placebo + Atorvastatin | 4 | |
| Weeks 9-12 / 20mg Dose Level | STARTED | Lovaza(Omacor) + Atorvastatin | 118 | |
| Weeks 9-12 / 20mg Dose Level | STARTED | Placebo + Atorvastatin | 118 | |
| Weeks 9-12 / 20mg Dose Level | COMPLETED | Lovaza(Omacor) + Atorvastatin | 113 | |
| Weeks 9-12 / 20mg Dose Level | COMPLETED | Placebo + Atorvastatin | 113 | |
| Weeks 9-12 / 20mg Dose Level | NOT COMPLETED | Lovaza(Omacor) + Atorvastatin | 5 | |
| Weeks 9-12 / 20mg Dose Level | NOT COMPLETED | Placebo + Atorvastatin | 5 | |
| Weeks 13-16 / 40mg Dose Level | STARTED | Lovaza(Omacor) + Atorvastatin | 113 | |
| Weeks 13-16 / 40mg Dose Level | STARTED | Placebo + Atorvastatin | 113 | |
| Weeks 13-16 / 40mg Dose Level | COMPLETED | Lovaza(Omacor) + Atorvastatin | 108 | |
| Weeks 13-16 / 40mg Dose Level | COMPLETED | Placebo + Atorvastatin | 111 | |
| Weeks 13-16 / 40mg Dose Level | NOT COMPLETED | Lovaza(Omacor) + Atorvastatin | 5 | |
| Weeks 13-16 / 40mg Dose Level | NOT COMPLETED | Placebo + Atorvastatin | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00435045/flow